It has been 17 years since the first publication of the Scandinavian Simvastatin Survival Study (Lancet 1994;344; 1383-9) describing the benefit of coenzyme A reductase inhibitors (statins) on cardiovascular events in patients with coronary heart disease.
What does 4S stand for?
4S stands for Scandinavian Simvastatin Survival Study (clinical trial; cardiology)
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Organizations, NGOs, schools, universities, etc.
See other definitions of 4S
- Four Phase Sequence
- Pantawid Pamilyang Pilipino Program (Philippines poverty reduction program)
- Product, Price, Place, Promotion (marketing)
- Public Private Partnerships Programme (UK)
- Four-Level Phase Shift Keying
- Enquiry/Investigation (police incident code; New Zealand)
- Fourth Quarter
- Four Soft Limited (Hyderabad, India)
- Sales, Service, Spare parts supply and Survey (automotive)
- Sales, Showroom, Service, Stockyard
- Society for Social Studies of Science
- Super Safe, Small, and Simple (nuclear reactor built by Toshiba)
- Vehicle servicing ie petrol/LPG (police incident code; New Zealand)
- Simon's SOAP Server Services for COM
- Four Stroke Direct Injection (engine)
- Four-Trails (Camp Miniwanca)
- Quarto (book paper size)
- Townsville, Queensland (Australian radio station)
Samples in periodicals archive:
The Scandinavian Simvastatin Survival Study (3) enrolled patients with coronary artery disease and hypercholesterolemia [average TC, 261 mg/dL (6.
Scandinavian Simvastatin Survival Study Group, "Randomized Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S)," Lancet 344 (1994):1383-89.
2,3) Although the results of the Scandinavian Simvastatin Survival Study (4S), (4) with its 7-year follow-up, are reassuring in terms of statin cancer risk, (1) the results of other recent studies are more disturbing.
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
A recent trial, known as the Scandinavian Simvastatin Survival Study, showed that drugs lowered the risk of heart attacks by 40 percent in diabetics.
The Scandinavian Simvastatin Survival Study (4S) assessed the effect of therapy with simvastatin on total mortality in 4,444 patients with CHD and baseline total cholesterol 212-309 mg/dL (5.
This was a high-risk population similar to patients enrolled in the Scandinavian Simvastatin Survival Study (4S) back in the 1990s, Dr.